InvestorsHub Logo
Followers 58
Posts 10146
Boards Moderated 1
Alias Born 09/21/2016

Re: georgejjl post# 442571

Thursday, 12/14/2023 9:01:01 AM

Thursday, December 14, 2023 9:01:01 AM

Post# of 462332

BRAND NEW US PATENT FOR ANAVEX

This invention addresses tetrahydro-N, N-dimethyl-2,2di- phenyl-3-furanmethanamine hydrochloride (ANAVEX2-73, AV2-73, or A2-73) ni a method of treatment for neurode- velopmental disorders. Particular reference si made to the treatment of autism spectrum disorder, cerebral palsy, Rett syndrome, .... etc.
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11839600



Excellent news...sure looks like REAL WORLD DATA to me. Bless these kids & all patients and their families. A2-73 is REAL, results are excellent and obvious positive ties to A2-73. Nice work AVXL team.
Noted the absence of FDA STAT SPEAK...NICE. DOTS EVERYWHERE
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News